cover image: High-cost users of pharmaceuticals

Premium

20.500.12592/2k1295

High-cost users of pharmaceuticals

23 Feb 2005

We acknowledge the financial support of the Department of Health of the Province of Manitoba. [...] The intent of the report was to compare high- cost prescription users to persons who are not high-cost users, in order to answer the question: “what explains high prescription costs?” The primary vii objectives of this report were to characterize high-cost users by sociodemo- graphics, prescription medication costs and utilization, underlying condi- tions and use of the health care system. [...] Summary of Findings Few People yet Disproportionate Share of Prescription Costs High-cost users of prescription medications (average annual cost of $3,424) accounted for 5% of Manitobans taking prescription medications in 2000/01, yet contributed to 41% of total prescription expenditures that year. [...] This study provides a description, within the Province of Manitoba, with the rest of of high-cost users of prescription medications compared with the rest of the the population. [...] The third set of analyses examines predictors for two high-cost user groups: (1) continuing high users, individuals who were high- cost users in 2000/01 and who remained in the high-cost user group in 2001/02, and (2) non-continuing high-cost users who were in HIGH-COST USERS OF PHARMACEUTICALS 5 the high-cost use group in 2000/01 but not in 2001/02.
health chemicals medicine pharmacies health care prescription drugs therapy drug utilization comorbidity clinical medicine direct-to-consumer advertising polypharmacy chronic condition logistic regression health treatment health sciences medical drugs medical specialties virus disease diseases and conditions beta blocker pharmaceutical manitoba centre for health policy beta-blockers beta blocking agents h2-receptor blocker affective psychosis h2 antagonist

Authors

Kozyrskyj, Anita

ISBN
1896489206
Pages
71
Published in
Canada

Related Topics

All